Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-04-044311
Filing Date
2004-03-18
Accepted
2004-03-18 06:02:06
Documents
6
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 926990
3 ADDENDUM TO THE EMPLOYMENT LETTER DATED 02/11/2003 dex1025.htm EX-10.25 27601
4 CONSENT OF ERNST & YOUNG dex231.htm EX-23.1 1703
5 CERTIFICATION OF CEO PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT dex311.htm EX-31.1 9650
6 CERTIFICATION OF CFO PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT dex312.htm EX-31.2 9827
7 CERTIFICATION OF CEO & CFO PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT dex321.htm EX-32.1 4452
  Complete submission text file 0001193125-04-044311.txt   982572
Mailing Address 2950 WILDERNESS PLACE BOULDER CO 80301
Business Address 2950 WILDERNESS PLACE BOULDER CO 80301 3034496500
SIRNA THERAPEUTICS INC (Filer) CIK: 0000892112 (see all company filings)

EIN.: 341697351 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-27914 | Film No.: 04676644
SIC: 2834 Pharmaceutical Preparations